COVID-19 vaccination in people with HIV, a pending issue
Two studies by CEEISCAT with the PISCIS cohort show that people living with HIV have been less vaccinated with the full initial regimen against COVID-19
At the IGTP TODAY
Two studies by CEEISCAT with the PISCIS cohort show that people living with HIV have been less vaccinated with the full initial regimen against COVID-19
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.
The Germans Trias i Pujol Research Institute (IGTP) has received funding to develop four projects as part of the "Public-Private Collaboration Projects" call by the State Research Agency of the Ministry of Science and Innovation, amounting to a total of €1,706,019.92.
The network IMMUNO-model has brought together researchers and innovators from all over the world to foster research in immuno-oncology through the advancement in the development and implementation of pre-clinical models. This initiative is funded by the European Cooperation in Science and Technology (COST) programme.
Two studies by CEEISCAT-IGTP have evaluated an online HIV and HCV self-testing strategy, demonstrating that it is effective and safe.
Institutions in and around the Can Ruti Campus have come together to develop Innomed, a programme aimed at sharing skills, knowledge, and resources to boost innovation. The initiative has recently received support from the ITEMAS platform.
Fundació Catalunya La Pedrera provides these awards, supporting and enhancing the careers of young talents with both its own resources and contributions from the ICS Gerència Territorial Metropolitana Nord.
The funds raised in the 2022 edition of La Marató de 3Cat will enable 71 research teams to conduct 37 projects in cardiovascular health to advance in the prevention, diagnosis, and treatment of diseases that represent the leading cause of death in developed countries. One of the awarded projects involves the participation of researchers from the GCAT of the IGTP, and is coordinated by Dr Camille Lassale from ISGlobal.
The research, led by Cima Universidad de Navarra, sheds light on new possibilities for addressing various types of cancer. This work has been carried out in collaboration with Dr Carolina Armengol, leader of IGTP’s Childhood Liver Oncology (C-LOG) group, a pioneer in the study of childhood liver cancer in Spain.